Cancer is now a disease with a number of highly effective treatment options that are leading to a greater number of cancer survivors who are living long and productive lives. Globally, there are 10 million people diagnosed with cancer, and 10% of newly diagnosed men and women are under the age of 40 years. While aggressive radiation and chemotherapies are able to save and prolong their lives, disruption of reproductive function-including fertility and endocrine function-can be an unintended consequence that is particularly relevant for these young cancer patients. We have also come to recognize that many young women have non-malignant conditions or must undergo treatment with drugs or procedures that can damage their reproductive function. The proposed Northwestern University Center for Reproductive Health After Disease will therefore extend the overall scope of work to ensure that these women are provided options for protecting their reproductive health and that providers are aware of the threat posed by specific diseases and treatments on reproductive function. Moreover, our Center will not be limited to the preservation of fertility but will also address the long-term endocrine health of women who lose gonadal function. There are 20,000 women between the ages of 41 and 51 who are diagnosed with cancer each year, and while these women lie outside the age limit for experimental fertility interventions, they are in need of alternatives that will preserve ovarian endocrine support of various tissues, such as bone. The overall hypothesis of the Center is that effective options can be provided to young women with malignant or non-malignant disease who must undergo life-preserving cancer treatments and other medical interventions that will affect their reproductive health. By assembling a diverse, cross-disciplinary team of investigators, the Center will pursue both basic scientific research and clinical research goals, as well as create and implement educational and community outreach initiatives to share the Center's findings with providers, patients, their families, and the public Center researchers will investigate new techniques for producing healthy, mature oocytes from the pool of immature oocytes in ovarian tissue banked by young cancer patients. Another project will examine the cellular mechanisms that might be targeted to protect eggs from the damaging effects of radiation and chemotherapy; this work will be particularly important for preserving endocrine health in older women. Clinical research will be conducted to determine to what extent fertility concerns affect the medical decision making process of patients. With an expanded scope, a team-based approach to problem solving, and the goal of preserving not only fertility, but all aspects of reproductive health, our Center has the potential to impact the lives of many young women who are at risk of disease-related or iatrogenic infertility and endocrine dysfunction.

Public Health Relevance

A grim health diagnosis that threatens to damage reproductive health presents both patients and providers with the dual challenges of maximizing life expectancy with effective treatment regimens while protecting the future quality of life-including the ability to have a family-after the disease. The proposed Northwestern University Center for Reproductive Health After Disease will address the basic science need to understand human follicle and egg biology and pursue cutting-edge options for preserving reproductive health, while providing physicians, patients, their families, and the public with information about the risks posed by diseases and treatments to reproductive health that will lead to informed dialogue about options for preserving reproductive function.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Specialized Center (P50)
Project #
5P50HD076188-05
Application #
9257196
Study Section
Special Emphasis Panel (ZHD1-DSR-L (55))
Program Officer
Moss, Stuart B
Project Start
2013-04-01
Project End
2018-03-31
Budget Start
2017-04-01
Budget End
2018-03-31
Support Year
5
Fiscal Year
2017
Total Cost
$1,397,558
Indirect Cost
$490,614
Name
Northwestern University at Chicago
Department
Obstetrics & Gynecology
Type
Schools of Medicine
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Jakus, Adam E; Laronda, Monica M; Rashedi, Alexandra S et al. (2017) ""Tissue Papers"" from Organ-Specific Decellularized Extracellular Matrices. Adv Funct Mater 27:
Salama, Mahmoud; Woodruff, Teresa K (2017) Anticancer treatments and female fertility: clinical concerns and role of oncologists in oncofertility practice. Expert Rev Anticancer Ther 17:687-692
Woodruff, Teresa K (2017) A win-win for women's reproductive health: A nonsteroidal contraceptive and fertoprotective neoadjuvant. Proc Natl Acad Sci U S A 114:2101-2102
Goldman, Kara N; Chenette, Devon; Arju, Rezina et al. (2017) mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy. Proc Natl Acad Sci U S A 114:3186-3191
Finlayson, Courtney; Fritsch, Michael K; Johnson, Emilie K et al. (2017) Presence of Germ Cells in Disorders of Sex Development: Implications for Fertility Potential and Preservation. J Urol 197:937-943
Hurwitz, Lisa B; Lauricella, Alexis R; Hightower, Brianna et al. (2017) ""When You're a Baby You Don't Have Puberty"": Understanding of Puberty and Human Reproduction in Late Childhood and Early Adolescence. J Early Adolesc 37:925-947
McCracken, Jennifer M; Chalise, Prabhakar; Briley, Shawn M et al. (2017) C57BL/6 Substrains Exhibit Different Responses to Acute Carbon Tetrachloride Exposure: Implications for Work Involving Transgenic Mice. Gene Expr 17:187-205
Carvalho, Bruno Ramalho de; Kliemchen, Jhenifer; Woodruff, Teresa K (2017) Ethical, moral and other aspects related to fertility preservation in cancer patients. JBRA Assist Reprod 21:45-48
Lebbe, Marie; Taylor, Angela E; Visser, Jenny A et al. (2017) The Steroid Metabolome in the Isolated Ovarian Follicle and Its Response to Androgen Exposure and Antagonism. Endocrinology 158:1474-1485
Laronda, Monica M; McKinnon, Kelly E; Ting, Alison Y et al. (2017) Good manufacturing practice requirements for the production of tissue vitrification and warming and recovery kits for clinical research. J Assist Reprod Genet 34:291-300

Showing the most recent 10 out of 77 publications